Cargando…
Biological Evaluation and Molecular Dynamics Simulation of Chalcone Derivatives as Epidermal Growth Factor-Tyrosine Kinase Inhibitors
Targeted cancer therapy has become a high potential cancer treatment. Epidermal growth factor receptor (EGFR), which plays an important role in cell signaling, enhanced cell survival and proliferation, has been suggested as molecular target for the development of novel cancer therapeutics. In this s...
Autores principales: | Sangpheak, Kanyani, Tabtimmai, Lueacha, Seetaha, Supaphorn, Rungnim, Chompoonut, Chavasiri, Warinthorn, Wolschann, Peter, Choowongkomon, Kiattawee, Rungrotmongkol, Thanyada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471738/ https://www.ncbi.nlm.nih.gov/pubmed/30897725 http://dx.doi.org/10.3390/molecules24061092 |
Ejemplares similares
-
Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines
por: Sangpheak, Kanyani, et al.
Publicado: (2018) -
Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
por: Aiebchun, Thitinan, et al.
Publicado: (2021) -
Pharmacophore-Based
Virtual Screening and Experimental
Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2022) -
In Silico and In Vitro Study of Janus Kinases Inhibitors from Naphthoquinones
por: Sanachai, Kamonpan, et al.
Publicado: (2023) -
Discovery of JAK2/3
Inhibitors from Quinoxalinone-Containing
Compounds
por: Sanachai, Kamonpan, et al.
Publicado: (2022)